These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Boutron-Ruault MC; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sánchez MJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT Cancer Causes Control; 2017 May; 28(5):429-435. PubMed ID: 28205047 [TBL] [Abstract][Full Text] [Related]
6. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413 [TBL] [Abstract][Full Text] [Related]
7. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Rinaldi S; Dossus L; Lukanova A; Peeters PH; Allen NE; Key T; Bingham S; Khaw KT; Trichopoulos D; Trichopoulou A; Oikonomou E; Pera G; Larrañaga N; Martinez-Garcia C; Ardanaz E; Quirós JR; Tormo MJ; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Linseisen J; Schulz M; Boeing H; van Gils CH; Bueno-de-Mesquita BH; Pala V; Palli D; Panico S; Tumino R; Vineis P; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC; Lundin E; Agren A; Berglund G; Manjer J; Kumle M; Lund E; Slimani N; Saracci R; Riboli E; Kaaks R Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):23-9. PubMed ID: 17220328 [TBL] [Abstract][Full Text] [Related]
8. The effect of androgens on the risk of endometriosis sub-phenotypes and ovarian neoplasms: A Mendelian randomization study. Gjorgoska M; Rizner TL J Steroid Biochem Mol Biol; 2024 May; 239():106482. PubMed ID: 38369034 [TBL] [Abstract][Full Text] [Related]
9. Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study. Schock H; Fortner RT; Surcel HM; Grankvist K; Pukkala E; Lehtinen M; Lundin E Int J Cancer; 2015 Jul; 137(2):439-47. PubMed ID: 25516257 [TBL] [Abstract][Full Text] [Related]
10. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Trabert B; Michels KA; Anderson GL; Brinton LA; Falk RT; Geczik AM; Harris HR; Pan K; Pfeiffer RM; Qi L; Rohan T; Wentzensen N; Xu X Int J Cancer; 2019 Oct; 145(8):2051-2060. PubMed ID: 30684389 [TBL] [Abstract][Full Text] [Related]
11. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344 [TBL] [Abstract][Full Text] [Related]
12. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066 [TBL] [Abstract][Full Text] [Related]
13. High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium. Peres LC; Mallen AR; Townsend MK; Poole EM; Trabert B; Allen NE; Arslan AA; Dossus L; Fortner RT; Gram IT; Hartge P; Idahl A; Kaaks R; Kvaskoff M; Magliocco AM; Merritt MA; Quirós JR; Tjonneland A; Trichopoulou A; Tumino R; van Gils CH; Visvanathan K; Wentzensen N; Zeleniuch-Jacquotte A; Tworoger SS Cancer Res; 2019 Oct; 79(20):5442-5451. PubMed ID: 31462430 [TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer]. Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477 [No Abstract] [Full Text] [Related]
15. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition. Travis RC; Key TJ; Allen NE; Appleby PN; Roddam AW; Rinaldi S; Egevad L; Gann PH; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Sieri S; Vineis P; Palli D; Quirós JR; Ardanaz E; Chirlaque MD; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Bikou C; Trichopoulos D; Stattin P; Jenab M; Ferrari P; Slimani N; Riboli E; Kaaks R Int J Cancer; 2007 Sep; 121(6):1331-8. PubMed ID: 17514649 [TBL] [Abstract][Full Text] [Related]
16. Plasma androgen concentrations and risk of incident ovarian cancer. Tworoger SS; Lee IM; Buring JE; Hankinson SE Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer. Parchwani D; Dholariya SJ; Takodara S; Singh R; Sharma VK; Saxena A; Patel DD; Radadiya M J Lab Physicians; 2022 Mar; 14(1):47-56. PubMed ID: 36105913 [No Abstract] [Full Text] [Related]
18. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045 [TBL] [Abstract][Full Text] [Related]
19. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort. Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536 [TBL] [Abstract][Full Text] [Related]